Rize Oncology

Kelowna, Canada

Rize Oncology develops a platform that allows to conjugate or tether donor DNA templates.

$358K raised

Oct 2025

Post-IPO Equity

Biotechnology Genetics Health Care

Top Investors

William Garner André Pereira Fraga Figueiredo

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rize Oncology

How much funding has Rize Oncology raised?

Rize Oncology has raised $358K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.

Who are Rize Oncology's investors?

Rize Oncology's investors include William Garner, André Pereira Fraga Figueiredo.

Where is Rize Oncology headquartered?

Rize Oncology is headquartered in Kelowna, Canada.

What does Rize Oncology do?

Rize Oncology develops a platform that allows to conjugate or tether donor DNA templates.

What stage is Rize Oncology at?

Rize Oncology is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 30, 2025.

MLA

"Rize Oncology — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/rize-oncology. Accessed July 3, 2026.

APA

VCBacked. (2025). Rize Oncology — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/rize-oncology

Wikipedia (cite web)

{{cite web |title=Rize Oncology — Funding & Investors |url=https://www.vcbacked.co/company/rize-oncology |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 30, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K